Professional Summary
Professional Overview
Ryan Wilhelm is an experienced entrepreneur and strategic consultant with a focus on the biotechnology and healthcare technology sectors. As the Co-Founder of Addicaid, he leads the development and implementation of innovative solutions to address addiction and mental health challenges. Additionally, he serves as an E-Lab NYC Fellow, leveraging his expertise to support the growth of promising startups in the bio and health tech industries.
Experience Summary
Current Role
As the Co-Founder of Addicaid, Ryan oversees the company's strategic direction, product development, and business operations. Under his leadership, Addicaid has emerged as a leading provider of digital tools and resources that empower individuals to manage addiction and mental health conditions effectively. Ryan's commitment to driving positive change in the healthcare landscape has been recognized through the company's selection for the Dreamit Ventures accelerator program.
Career Progression
Prior to co-founding Addicaid, Ryan gained valuable experience as a Strategy Consultant at JP Art Acquisition, where he provided strategic advisory services to art-related businesses. He also co-founded ClosetDash, a technology-driven fashion startup, demonstrating his entrepreneurial drive and ability to build successful ventures.
Academic Background
Ryan holds a Bachelor's degree from a prestigious university, where he cultivated a strong foundation in business strategy and entrepreneurship. His academic achievements and specialized knowledge in the fields of biotechnology and healthcare technology have been instrumental in shaping his professional trajectory.
Areas of Expertise
- Entrepreneurship and startup management
- Digital health and biotechnology innovation
- Strategic consulting and business development
- Addiction and mental health treatment solutions
- Project management and team leadership
Professional Impact
As a Co-Founder of Addicaid, Ryan has spearheaded the development of cutting-edge digital tools that have positively impacted the lives of individuals struggling with addiction and mental health challenges. Through his role as an E-Lab NYC Fellow, he continues to contribute to the growth and success of promising startups in the bio and health tech industries, leveraging his extensive knowledge and network to drive meaningful change.
Conclusion
With a proven track record of entrepreneurial success and strategic consulting expertise, Ryan Wilhelm is positioned to make a lasting impact in the biotechnology and healthcare technology sectors. Driven by a passion for innovation and a commitment to addressing critical societal challenges, he remains focused on expanding the reach and capabilities of Addicaid while actively contributing to the broader ecosystem of bio and health tech startups.
